Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation.

PubWeight™: 6.78‹?› | Rank: Top 1%

🔗 View Article (PMID 11323696)

Published in Nat Immunol on May 01, 2001

Authors

M J van Stipdonk1, E E Lemmens, S P Schoenberger

Author Affiliations

1: Division of Immune Regulation, La Jolla Institute for Allergy and Immunology, 10355 Science Center Drive San Diego, CA 92121, USA.

Articles citing this

(truncated to the top 100)

Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity (2007) 9.26

CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol (2004) 6.80

Memory CD8 T-cell differentiation during viral infection. J Virol (2004) 6.75

Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J Exp Med (2008) 5.71

Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med (2002) 5.64

Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. J Exp Med (2004) 5.08

Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity (2010) 4.52

Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J Clin Invest (2001) 4.37

CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J Exp Med (2002) 3.28

Antigen-driven effector CD8 T cell function regulated by T-bet. Proc Natl Acad Sci U S A (2003) 3.23

Dendritic cells maximize the memory CD8 T cell response to infection. Immunity (2005) 3.21

Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J Virol (2002) 3.21

Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response. J Exp Med (2005) 3.14

Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy. Trends Immunol (2005) 2.97

Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells. J Exp Med (2004) 2.59

Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation. J Exp Med (2005) 2.59

Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs. J Exp Med (2008) 2.55

The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol (2010) 2.53

FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc Natl Acad Sci U S A (2008) 2.52

Cross-priming in health and disease. Nat Rev Immunol (2010) 2.51

Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. J Clin Invest (2005) 2.48

Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells. Nat Immunol (2009) 2.32

Heterologous immunity between viruses. Immunol Rev (2010) 2.20

Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8+ T cell response. J Exp Med (2006) 2.18

Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection. J Virol (2002) 2.14

Interferon-gamma acts directly on CD8+ T cells to increase their abundance during virus infection. J Exp Med (2005) 2.13

Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J Immunol (2009) 2.08

Nucleoporin levels regulate cell cycle progression and phase-specific gene expression. Dev Cell (2008) 2.00

Interleukin-2 enhances CD4+ T cell memory by promoting the generation of IL-7R alpha-expressing cells. J Exp Med (2007) 1.99

Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells. Nat Immunol (2011) 1.98

Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. J Clin Invest (2002) 1.98

Therapeutic cancer vaccines: are we there yet? Immunol Rev (2011) 1.86

Generation of effector CD8+ T cells and their conversion to memory T cells. Immunol Rev (2010) 1.85

DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med (2011) 1.79

In situ imaging of the endogenous CD8 T cell response to infection. Science (2007) 1.78

SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling. J Clin Invest (2005) 1.75

Cutting edge: latecomer CD8 T cells are imprinted with a unique differentiation program. J Immunol (2006) 1.73

Recruitment times, proliferation, and apoptosis rates during the CD8(+) T-cell response to lymphocytic choriomeningitis virus. J Virol (2001) 1.72

Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets. PLoS One (2007) 1.72

Increased competition for antigen during priming negatively impacts the generation of memory CD4 T cells. Proc Natl Acad Sci U S A (2007) 1.71

Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation. J Exp Med (2007) 1.68

Persistent antigen presentation after acute vesicular stomatitis virus infection. J Virol (2006) 1.68

High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS One (2010) 1.68

Tracking the total CD8 T cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts. J Immunol (2009) 1.68

Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma. Blood (2009) 1.61

Requirement of B cells for generating CD4+ T cell memory. J Immunol (2009) 1.60

Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J Clin Invest (2006) 1.59

Plasticity in programming of effector and memory CD8 T-cell formation. Immunol Rev (2010) 1.59

Exploring regulatory mechanisms of CD8+ T cell contraction. Proc Natl Acad Sci U S A (2008) 1.55

Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses. Proc Natl Acad Sci U S A (2004) 1.55

IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection. Proc Natl Acad Sci U S A (2010) 1.54

Transient viremia, plasma viral load, and reservoir replenishment in HIV-infected patients on antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 1.54

Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection. Proc Natl Acad Sci U S A (2007) 1.51

Programming CD8+ T cells for effective immunotherapy. Curr Opin Immunol (2006) 1.51

Generation and maintenance of memory CD4(+) T Cells. Curr Opin Immunol (2009) 1.50

Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infection. J Clin Invest (2002) 1.50

Early signals during CD8 T cell priming regulate the generation of central memory cells. J Immunol (2010) 1.49

Memory CD8+ T cell differentiation. Ann N Y Acad Sci (2010) 1.47

Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation. J Exp Med (2004) 1.46

CD8 T cell competition for dendritic cells in vivo is an early event in activation. Proc Natl Acad Sci U S A (2006) 1.46

A comparison of random vs. chemotaxis-driven contacts of T cells with dendritic cells during repertoire scanning. J Theor Biol (2007) 1.45

The CD8 response on autopilot. Nat Immunol (2001) 1.45

Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination. J Exp Med (2007) 1.44

Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens. J Exp Med (2002) 1.44

The Erk2 MAPK regulates CD8 T cell proliferation and survival. J Immunol (2008) 1.44

The activation and inactivation of mature CD4 T cells: a case for peripheral self-nonself discrimination. Scand J Immunol (2014) 1.41

Prolonged antigen presentation is required for optimal CD8+ T cell responses against malaria liver stage parasites. PLoS Pathog (2010) 1.39

Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc Natl Acad Sci U S A (2011) 1.39

Immune memory redefined: characterizing the longevity of natural killer cells. Immunol Rev (2010) 1.36

Quantifying T lymphocyte turnover. J Theor Biol (2013) 1.35

An IFN-gamma-IL-18 signaling loop accelerates memory CD8+ T cell proliferation. PLoS One (2008) 1.35

The complex interplay between autophagy, apoptosis, and necrotic signals promotes T-cell homeostasis. Immunol Rev (2010) 1.35

CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity. Proc Natl Acad Sci U S A (2002) 1.34

OX40 drives protective vaccinia virus-specific CD8 T cells. J Immunol (2008) 1.33

Repeated stimulation of CD4 effector T cells can limit their protective function. J Exp Med (2005) 1.31

Cytokine-mediated programmed proliferation of virus-specific CD8(+) memory T cells. Immunity (2012) 1.31

CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production. J Clin Invest (2009) 1.29

Loss of T cell receptor-induced Bmi-1 in the KLRG1(+) senescent CD8(+) T lymphocyte. Proc Natl Acad Sci U S A (2007) 1.28

Consequences of immunodominant epitope deletion for minor influenza virus-specific CD8+-T-cell responses. J Virol (2005) 1.28

Organization of proximal signal initiation at the TCR:CD3 complex. Immunol Rev (2009) 1.25

Differential regulation of effector- and central-memory responses to Toxoplasma gondii Infection by IL-12 revealed by tracking of Tgd057-specific CD8+ T cells. PLoS Pathog (2010) 1.25

Dlgh1 coordinates actin polymerization, synaptic T cell receptor and lipid raft aggregation, and effector function in T cells. J Exp Med (2005) 1.25

Duration of antigen availability influences the expansion and memory differentiation of T cells. J Immunol (2011) 1.24

mTOR at the crossroads of T cell proliferation and tolerance. Semin Immunol (2007) 1.22

Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function. J Immunol (2004) 1.21

Commitment point during G0-->G1 that controls entry into the cell cycle. Mol Cell Biol (2003) 1.21

NSOM/QD-based nanoscale immunofluorescence imaging of antigen-specific T-cell receptor responses during an in vivo clonal Vγ2Vδ2 T-cell expansion. Blood (2007) 1.21

How antigen quantity and quality determine T-cell decisions in lymphoid tissue. Mol Cell Biol (2008) 1.20

Killer T cells regulate antigen presentation for early expansion of memory, but not naive, CD8+ T cell. Proc Natl Acad Sci U S A (2007) 1.20

Antigen kinetics determines immune reactivity. Proc Natl Acad Sci U S A (2008) 1.17

Secondary T cell-T cell synaptic interactions drive the differentiation of protective CD8+ T cells. Nat Immunol (2013) 1.14

Regulating mammalian target of rapamycin to tune vaccination-induced CD8(+) T cell responses for tumor immunity. J Immunol (2012) 1.13

Functional implications of T cell receptor diversity. Curr Opin Immunol (2009) 1.13

Mapping the life histories of T cells. Nat Rev Immunol (2010) 1.12

T cell and APC dynamics in situ control the outcome of vaccination. J Immunol (2010) 1.11

The acute phase protein haptoglobin regulates host immunity. J Leukoc Biol (2008) 1.10

Short-term antigen presentation and single clonal burst limit the magnitude of the CD8(+) T cell responses to malaria liver stages. Proc Natl Acad Sci U S A (2002) 1.10

Killing of dendritic cells: a life cut short or a purposeful death? J Exp Med (2001) 1.10

Delayed expansion and contraction of CD8+ T cell response during infection with virulent Salmonella typhimurium. J Immunol (2006) 1.09

Maturation-dependent licensing of naive T cells for rapid TNF production. PLoS One (2010) 1.09

Articles by these authors

CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat Med (1999) 2.77

Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J Exp Med (2000) 1.54

Role of antigen-presenting cells in mediating tolerance and autoimmunity. J Exp Med (2000) 1.46

Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus. Proc Natl Acad Sci U S A (2001) 1.28

Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. J Immunol (1998) 1.12

Functional cooperation between T helper cell determinants. Proc Natl Acad Sci U S A (2000) 1.09

CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity. Semin Immunol (1998) 1.04

Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction. J Clin Invest (2000) 0.94

Efficient loading of HLA-DR with a T helper epitope by genetic exchange of CLIP. Proc Natl Acad Sci U S A (1997) 0.94

The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA. J Immunol (2001) 0.93

Cryptic open reading frames in plasmid vector backbone sequences can provide highly immunogenic cytotoxic T-lymphocyte epitopes. Cancer Res (1998) 0.86

Tumor rejection antigens and tumor specific cytotoxic T lymphocytes. Behring Inst Mitt (1994) 0.78

Activation or frustration of anti-tumor responses by T-cell-based immune modulation. Semin Immunol (1997) 0.76